Talkspace Inc(TALK) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | 0 | Insider Own | 0.41% | Shs Outstand | 165.8M | Perf Week | - |
| Market Cap | 0.87B | Forward P/E | - | EPS next Y | - | Insider Trans | -12.31% | Shs Float | 165.2M | Perf Month | 0.57% |
| Enterprise Value | 0.78B | PEG | - | EPS next Q | - | Inst Own | 74.51% | Short Float | 2.94% | Perf Quarter | 1.16% |
| Income | 0.00B | P/S | 3.54 | EPS this Y | - | Inst Trans | 10.84% | Short Ratio | 2.45 | Perf Half Y | 9.38% |
| Sales | 0.25B | P/B | 7.76 | EPS next 5Y | - | ROA | 0.14% | Short Interest | 4.86M | Perf YTD | 44.63% |
| Book/sh | 0.68 | P/C | 9.57 | EPS past 3/5Y | - | ROE | 0.17% | 52W High | 0% ($5.25) | Perf Year | 107.51% |
| Cash/sh | 0.55 | P/FCF | 188.84 | Sales past 3/5Y | 24.16% 24.61% | ROIC | 0.17% | 52W Low | 110.84% ($2.49) | Perf 3Y | 224.07% |
| Dividend Est. | - | EV/EBITDA | 552.88 | EPS Y/Y TTM | -91.18% | Gross Margin | 39.62% | Volatility(W/M) | 0.27% 0.38% | Perf 5Y | -0.19% |
| Dividend TTM | - | EV/Sales | 3.17 | Sales Y/Y TTM | 21.28% | Oper. Margin | -1.31% | ATR (14) | 0.02 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.52 | EPS Q/Q | -184.38% | Profit Margin | 0.08% | RSI (14) | 59.17 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.52 | Sales Q/Q | 13.56% | SMA20 | 0.6% ($5.22) | Beta | 1.12 | Target Price | $5.62 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/05/05 | SMA50 | 0.7% ($5.21) | Rel Volume | 0 | Prev Close | $5.25 |
| Employees | 598 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -40.99% -1.17% | SMA200 | 15.58% ($4.54) | Avg Volume(3M) | 1.99M | Price | $5.25 |
| IPO | 2020/7/30 | Option/Short | Yes/No | Trades | 0 | Volume | - | Change | - |
🧠 Talkspace is a US-based tele-behavioral health company that operates a virtual mental health platform built around chat, voice, and video. It connects users with licensed therapists and psychiatric providers, offering online counseling and medication management, and delivers its services through insurers, employers, and direct-to-consumer channels. The company is focused on lowering the barriers to mental health care by leveraging digital accessibility.
Over the past 1 year, on the higher side
0% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
TALK has a sound balance sheet but weak earning power
Of every $100 in sales, $1.31 is lost.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $354. Peers typically go for $166. Compared with its own 2-year average, it is 2685% pricier now.
Tap to view numbers
Not enough quarters to judge yet
Only 1 quarter(s) reported, so no grade yet.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -0.2%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 74.5%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #17 of 42 in the industry
Based on market cap of $871M.
FAQ
What kind of company is TALK?
TALK belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of TALK?
The market cap of TALK is approximately $871M, ranking 2,787 within its sector.
What is the 52-week high and low for TALK?
TALK has recorded a 52-week high of $5.25 and a low of $2.49.